Analyzing Anzu Special Acquisition Corp I (NASDAQ:ANZUW) & Biosig Technologies (NASDAQ:STEX)

Anzu Special Acquisition Corp I (NASDAQ:ANZUW) and Biosig Technologies (NASDAQ:STEX) are both manufacturing companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, analyst recommendations and valuation.

Institutional and Insider Ownership

7.2% of Biosig Technologies shares are owned by institutional investors. 52.7% of Biosig Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Anzu Special Acquisition Corp I and Biosig Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Anzu Special Acquisition Corp I	N/A	N/A	N/A
Biosig Technologies	N/A	-717.92%	-336.75%

Analyst Recommendations

This is a summary of current ratings and recommmendations for Anzu Special Acquisition Corp I and Biosig Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anzu Special Acquisition Corp I	0	0	0	0	0.00
Biosig Technologies	1	0	1	0	2.00

Biosig Technologies has a consensus target price of $8.00, suggesting a potential upside of 773.74%. Given Biosig Technologies’ stronger consensus rating and higher possible upside, analysts clearly believe Biosig Technologies is more favorable than Anzu Special Acquisition Corp I.

Valuation and Earnings

This table compares Anzu Special Acquisition Corp I and Biosig Technologies”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anzu Special Acquisition Corp I	N/A	N/A	N/A	N/A	N/A
Biosig Technologies	$40,000.00	4,161.40	-$462.77 million	($9.71)	-0.09

Anzu Special Acquisition Corp I has higher earnings, but lower revenue than Biosig Technologies.

Summary

Biosig Technologies beats Anzu Special Acquisition Corp I on 6 of the 8 factors compared between the two stocks.

About Anzu Special Acquisition Corp I

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices, such as auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

About Biosig Technologies

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company’s proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.